Skip to content
Disclosery

13F-HR filed by Euclidean Capital LLC

Euclidean Capital LLC filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-15, with 10 holding rows worth $113,974,917.

Accession
0001012975-23-000226
Filer
CIK 1825034
Filed
2023-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2023

A holdings report, 10 entries on the cover page, a total value of $113,974,917 stated on the cover page (in dollars after the unit check, H1), rows summing to $113,974,917 with VALUE read as dollars as filed, 13F file number 028-20777. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ISHARES TR46429B598MSCI INDIA ETF1,200,144$47,237,668dollars as filed
23ANDME HOLDING CO90138Q108CLASS A COM10,243,122$23,354,318dollars as filed
PMV PHARMACEUTICALS INC69353Y103COM2,336,909$11,147,056dollars as filed
RAPT THERAPEUTICS INC75382E109COM432,900$7,943,715dollars as filed
FOGHORN THERAPEUTICS INC344174107COMMON STOCK1,261,261$7,819,818dollars as filed
ALECTOR INC014442107COMMON STOCK980,894$6,071,734dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM747,550$4,261,035dollars as filed
NGM BIOPHARMACEUTICALS INC62921N105COM746,674$3,046,430dollars as filed
TENAYA THERAPEUTICS INC87990A106COM915,705$2,609,759dollars as filed
Surrozen, Inc.86889P109COM802,963$483,384dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001012975-23-000226this filing2023-05-15acceptance time not in the bulk data set